Developmental and epileptic encephalopathies (DEE) are a group of severe epilepsies that usually present with intractable seizures, developmental delay and are at a higher risk for premature mortality. Numerous genes have been identified as a monogenic cause of DEE, including KCNB1. The voltage-gated potassium channel K V 2.1, encoded by KCNB1, is primarily responsible for delayed rectifier potassium currents that are important regulators of excitability in electrically excitable cells, including neurons and cardiomyocytes. The de novo pathogenic variant KCNB1-p.G379R was identified in an infant with epileptic spasms, atonic, focal and tonic-clonic seizures that were refractory to treatment with standard antiepileptic drugs. Previous work demonstrated deficits in potassium conductance, but did not assess non-conducting functions. To determine if the G379R variant affected clustering at endoplasmic reticulum-plasma membrane junctions K V 2.1-G379R was expressed in HEK293T cells. K V 2.1-G379R expression did not induce formation of endoplasmic reticulum-plasma membrane junctions, and coexpression of K V 2.1-G379R with K V 2.1-WT lowered induction of these structures relative to K V 2.1-WT alone, suggesting a dominant negative effect. To model this variant in vivo, we introduced Kcnb1 G379R into mice using CRISPR/Cas9 genome editing. We characterized neurological and neurobehavioral phenotypes of Kcnb1 G379R/+ (Kcnb1 R/+ ) and Kcnb1 G379R/G379R (Kcnb1 R/R ) mice, and screened for cardiac abnormalities. Immunohistochemistry studies on brains from Kcnb1 +/+ (WT), Kcnb1 R/+ and Kcnb1 R/R mice revealed genotype-dependent differences in the levels and subcellular localization of K V 2.1, with reduced plasma membrane expression of the K V 2.1-G379R protein, consistent with in vitro data. Kcnb1 R/+ and Kcnb1 R/R mice displayed profound hyperactivity, repetitive behaviors, impulsivity and reduced anxiety. In addition, both Kcnb1 R/+ and Kcnb1 R/R mice exhibited abnormal interictal EEG abnormalities, including isolated spike and slow waves. Spontaneous seizure events were observed in Kcnb1 R/R mice during exposure to novel environments and/or handling, while both Kcnb1 R/+ and Kcnb1 R/R mutants were more susceptible to induced seizures. Kcnb1 R/+ and Kcnb1 R/R mice exhibited prolonged rate-corrected QT interval on surface ECG recording. Overall, the Kcnb1 G379R mice recapitulate many features observed in individuals with DEE due to pathogenic variants in KCNB1. This new mouse model of KCNB1 associated DEE will be valuable for improving the understanding of the underlying pathophysiology and will provide a valuable tool for the development of therapies to treat this pharmacoresistant DEE.
Introduction
Developmental and epileptic encephalopathies (DEE) are a group of severe disorders that present early in life and are characterized by paroxysmal activity on EEG, multiple seizure types that are often medically intractable, and serious cognitive, behavioral and neurological deficits (Berg et al., 2010; Scheffer et al., 2017) . In 30-50% of infants diagnosed with an epileptic encephalopathy, a causative mutation has been identified in a known epilepsy gene (McTague et al., 2016) . Previous work has identified heterozygous de novo KCNB1 pathogenic variants in individuals with DEE (Allen et al., 2016; Bar et al., 2019; Calhoun et al., 2017; de Kovel et al., 2017; Latypova et al., 2017; Marini et al., 2017; Miao et al., 2017; Saitsu et al., 2015; Thiffault et al., 2015; Torkamani et al., 2014) . In addition to seizures, individuals with KCNB1 variants display comorbidities that include developmental delay, intellectual disability, features of autism spectrum disorder, ADHD and aggression (Bar et al., 2019; Calhoun et al., 2017; de Kovel et al., 2017; Marini et al., 2017) . Since the initial reports of KCNB1 variants in early infantile epileptic encephalopathy type 26 (EIEE26), the phenotype has expanded to include cases with less severe and/or later onset epilepsy or no discrete seizures, and thus the term KCNB1 encephalopathy encompasses this broader phenotype spectrum.
The KCNB1-G379R variant was identified in a male child with seizures commencing at 8 months of age (Torkamani et al., 2014) . Glycine 379 is located in the KV2.1 channel ion selectivity filter and is an evolutionarily invariant residue critical for potassium selectivity, supporting pathogenicity of the G379R missense variant ( Figure 1A ) (Kuang et al., 2015) . The epilepsy phenotype included infantile spasms, atonic, focal, and tonic-clonic seizures that were refractory to various antiepileptic therapies, including topiramate, valproic acid, pyridoxine, ACTH, and the ketogenic diet. (Torkamani et al., 2014) . At 15 months of age, hypsarrhythmia was present on EEG and later in childhood, monitoring revealed multifocal and diffuse polyspikes, polyspike and slow waves, right temporal spike and slow waves, left occipital spikes, and diffuse polyspike bursts (Torkamani et al., 2014) . The individual also had severe motor and language delays, autism spectrum disorder, stereotypies, hand-wringing, and strabismus, as well as borderline line QT syndrome (de Kovel et al., 2017; Srivastava et al., 2018; Torkamani et al., 2014) .
KCNB1 encodes the KV2.1 voltage-gated potassium channel subunit that is primarily responsible for delayed rectifier potassium current, an important regulator of neuronal excitability (Guan et al., 2007; Hönigsperger et al., 2017; Liu and Bean, 2014; Murakoshi and Trimmer, 1999; Palacio et al., 2017) . KV2.1 is expressed at high levels in various neurons and localized to high-density clusters on the soma, proximal dendrites and axon initial segment (Bishop et al., 2015; Du et al., 1998; Sarmiere et al., 2008; Trimmer, 1991) . KV2.1 clusters align with endoplasmic reticulum (ER) and plasma membrane (PM) junctions, membrane microdomains important in calcium and lipid signaling and homeostasis (Bishop et al., 2018; Bishop et al., 2015; Dickson, 2017; Du et al., 1998; Gallo et al., 2016; Henne et al., 2015; Mandikian et al., 2014; Wu et al., 2017) . KV2.1 serves a structural role at EM-PM junctions independent of its potassium conducting function by binding to the ER proteins VAPA and VAPB, resulting in the recruitment of the ER to the PM (Fox et al., 2015; Johnson et al., 2018; Kirmiz et al., 2018a; Kirmiz et al., 2018b) . In addition to neuronal expression, KV2.1 is also expressed in rodent heart within high-density clusters in atrial myocytes, as well as non-clustered KV2.1 in ventricular transverse-axial tubules and sarcolemma (O'Connell et al., 2008) .
Several KCNB1 variants have been functionally characterized in vitro and shown to exhibit reduced KV2.1 conductance, as well as altered ion selectivity, expression and localization (Saitsu et al., 2015; Thiffault et al., 2015; Torkamani et al., 2014) . KV2.1-G379R channels exhibited loss of voltage-sensitivity and ion-selectivity, resulting in a non-specific cation leak conductance (Torkamani et al., 2014) . When co-expressed with wild-type (WT) KV2.1 subunits, KV2.1-G379R exerted dominant-negative effects on potassium conductance (Torkamani et al., 2014) .
In the present study, we evaluated the effect of the DEE-associated KCNB1-G379R variant on KV2.1 expression and clustering in HEK293T cells and observed a dominant negative effect on ER-PM clustering. To model this variant in vivo, we used CRISPR/Cas9 genome editing to generate a mouse model carrying the KCNB1-G379R pathogenic variant and characterized Kv2.1 expression and localization, as well as neurological, neurobehavioral, and cardiac phenotypes. Kcnb1 G379R mice exhibited spontaneous seizures, abnormal EEG patterns, profound hyperactivity, inattention/impulsivity, and reduced anxiety-like behavior. Furthermore, Kcnb1 G379R mice had prolonged heart-rate corrected QT intervals. These mice recapitulate core features of KCNB1-associated encephalopathy and will be a useful tool for understanding disease pathophysiology and evaluating potential therapies.
Materials and Methods

HEK293T cell culture, immunocytochemistry, and epifluorescence and TIRF imaging.
HEK293T cells were transfected with WT rat KV2.1 in pRBG4 , rat KV2.1 S586A in pCGN, HAtagged wildtype human KV2.1, or HA-tagged WT human KV2.1 with the G379R mutation (Kang et al., 2019; Lim et al., 2000; Shi et al., 1994) . Cells were transiently transfected using Lipofectamine 2000 following the manufacturer's protocol within 18 hours of plating. For experiments involving immunocytochemistry, fixation was performed as previously described (Dickson et al., 2016; Kirmiz et al., 2018b) . Briefly, HEK293T cells were fixed in 3.2% formaldehyde, blocked and permeabilized. Cells were incubated in monoclonal anti-HA epitope tag antibody 12CA5 (NeuroMab; RRID:AB_ 2532070, pure, 5 μg/mL) and monoclonal anti-VAPA antibody N479/24 (NeuroMab; RRID:AB_ 2722709, 1:5). Coverslips were immunolabeled with Alexa-conjugated fluorescent IgG subclass-specific secondary antibodies (ThermoFisher; 1:1500) and Hoechst 33258 dye (ThermoFisher H1399; 200 ng/mL).
Epifluorescence and TIRF imaging of fixed cells and image analysis was performed essentially as described (Bishop et al., 2018; Kirmiz et al., 2018b) . Images were obtained with an Andor iXon EMCCD camera installed on a TIRF/widefield equipped Nikon Eclipse Ti microscope using a Nikon LUA4 laser launch with 405, 488, 561 and 647 nm lasers and a 100x PlanApo TIRF/1.49 NA objective run with NIS Elements software (Nikon). Images were collected within NIS Elements as ND2 images. For further details, see supplemental materials and methods.
Mice. Kcnb1 G379R/+ mice on the C57BL/6J inbred strain were generated using CRISPR/Cas9 to introduce the modification of glycine 379 by homology directed repair. Three nucleotide changes were introduced, including two nucleotide changes in codon 379 (GGT > CGC) to maintain similar codon usage, and a silent change to disrupt an adjacent PAM site (C > A) ( Figure 1B) . A single guide RNA (TAGATGTCTCCGTAACCAA NGG) with good targeting efficiency in Neuro2A cells and low predicted off-target effects, and a 200 bp repair oligo (5'-TCTCCAGCCTGGTCTTCTTTGCCGAGAAGGATGAGGATGACACCAAGTTCAAAAGCA   TCCCCGCCTCTTTCTGGTGGGCTACCATCACCATGACGACAGTTCGCTACGGAGACA   TCTACCCTAAGACTCTCCTGGGGAAAATCGTGGGGGGCCTCTGTTGCATTGCCGGTG  TCCTGGTGATTGCCCTCCCCATTCCAATT) were microinjected into C57BL/6J embryos by   the Northwestern University Transgenic and Targeted Mutagenesis Laboratory. Potential founders were screened by PCR of genomic DNA using primers outside the repair oligo homology region (Table 1) , and the region of interest was TOPO-cloned and Sanger sequenced (n=12-22 clones per founder). The mosaic G379R founder was backcrossed to C57BL/6J mice (Jackson Labs, #000664, Bar Harbor, ME) to generate N1 offspring. N1 offspring were genotyped by Sanger sequencing to confirm transmission of the G379R editing event, and were screened for off-target events by Sanger sequencing of all potential sites with <3 mismatches. N1 mice with the confirmed on-target event and without off-target events were bred with C57BL/6J females to establish the line, Kcnb1 em1Kea , which is maintained by continual backcrossing of heterozygous Kcnb1 G379R/+ (Kcnb1 R/+ ) mice with inbred C57BL/6J mice. Male and female Kcnb1 R/+ mice were intercrossed to generate wild-type Kcnb1 +/+ (WT), heterozygous Kcnb1 R/+ , and homozygous Kcnb1 R/R mice for experiments. For immunohistochemistry experiments, Kcnb1 +/and Kcnb1 -/knockout mice (Kcnb1 tmDgen ) that we previously characterized were included for comparison (Speca et al., 2014) .
Mice were maintained in a Specific Pathogen Free (SPF) barrier facility with a 14-hour light/10-hour dark cycle and access to food and water ad libitum. (Table 1) . Reactions were partitioned into droplets in a QX200 droplet generator (Bio-Rad). PCR conditions were 95°C for 10 minutes, then 44 cycles of 95°C for 30 seconds and 60°C for 1 minute (ramp rate of 2°C/sec) and a final inactivation step of 98°C for 5 minutes. Following amplification, droplets were analyzed with a QX200 droplet reader with QuantaSoft v1.6.6 software (Bio-Rad) ( Figure 1C ). Transcript Analysis. Whole brain RNA was extracted from P27-32 WT, Kcnb1 R/+ and Kcnb1 R/R mice. Total RNA was isolated using TRIzol reagent according to the manufacturer's instructions.
First-strand cDNA was synthesized from 2 micrograms of RNA using oligo(dT) primer and Superscript IV reverse transcriptase (RT) according to the manufacturer's instructions (Life Technologies). First-strand cDNA samples were diluted 1:5 and 5 μl was used as template.
Quantitative ddPCR was performed using ddPCR Supermix for Probes (No dUTP) (Bio-Rad) and TaqMan Gene Expression Assays (Life Technologies) for mouse Kcnb1 (FAM-MGB-Mm00492791_m1) and Tbp (VIC-MGB-Mm00446971_m1) as a normalization standard.
Reactions were partitioned into a QX200 droplet generator (Bio-Rad). Thermocycling conditions and analysis were performed as described for genotyping. Both assays lacked detectable signal in no-RT and no template controls. Relative transcript levels were expressed as a ratio of Kcnb1 concentration to Tbp concentration, with 6-8 biological replicates per genotype. Statistical comparison between groups was made using ANOVA with Tukey's post-hoc comparisons (GraphPad Prism, San Diego, CA).
Immunblotting. Whole brain membrane proteins were isolated from P27-32 WT, Kcnb1 R/+ and 1:20,000) were used to detect signal on an Odyssey imaging system (Li-COR). Relative protein levels were determined by densitometry with ImageJ (NIH) (Rasband, 1997 (Rasband, -2018 or Image Studio (Li-COR) and expressed as a ratio of KV2.1, KV2.2 or AMIGO-1 to GRP75, with 6-7 biological replicates per genotype. Line scan analysis of KV2.1 immunoblots was performed in ImageJ and expressed as the average ± SEM. Statistical comparison between groups was made using one-way ANOVA with Tukey's post-hoc comparisons (GraphPad Prism).
Immunohistochemistry. Animals were deeply anesthetized with pentobarbital and transcardially perfused with 4% formaldehyde prepared from paraformaldehyde, in 0.1 M sodium phosphate buffer pH 7.4 (0.1 M PB). Sagittal brain sections (30 µm thick) were prepared and immunolabeled using free-floating methods as previously described (Palacio et al., 2017; Rhodes et al., 2004; Speca et al., 2014) . Briefly, free floating sections were blocked and permeabilized. Sections were incubated with primary antibodies and then immunolabeled with Alexa-conjugated fluorescent IgG subclass-specific secondary antibodies and Hoechst 33258 DNA stain (see Table 2 for antibody details). Images were taken using the same exposure time to compare the signal intensity directly. Images were identically processed in Photoshop to maintain consistency between samples. Labeling intensity within stratum pyramidale of hippocampal CA1 was measured using a rectangular region of interest (ROI) of 39 μm x 164 μm. To maintain consistency between samples, ROIs were obtained from a region within CA1 near the border of CA1 and CA2. Data points reflect the mean pixel intensity values of this ≈6400 μm 2 ROI. Values from multiple immunolabels and Hoechst dye were simultaneously measured from the same ROI. Background levels for individual labels were measured from no primary antibody controls and mathematically subtracted from ROI values.
For further details, see supplemental materials and methods.
Seizure Threshold Testing. Male and female WT, Kcnb1 R/+ and Kcnb1 R/R mice were tested between 3 and 12 weeks of age by experimenters blinded to genotype. Separate cohorts of mice were used for each inducing agent.
Flurothyl seizure induction. Susceptibility to seizures induced by the chemoconvulsant flurothyl (Bis(2,2,2-trifluoroethyl) ether, Sigma-Aldrich, St. Louis, MO) was assessed in WT, Kcnb1 R/+ and Kcnb1 R/R mice at P70-84. Flurothyl was introduced into a clear, plexiglass chamber by a syringe pump at a rate of 20 μL/min and allowed to volatilize. Latency to first generalized tonic-clonic seizure (GTCS) with loss of posture was recorded (n = 27-32 per genotype). Groups were compared using one-way ANOVA with Tukey's post-hoc comparisons (GraphPad Prism).
6 Hz seizure induction. Susceptibility to 6 Hz psychomotor seizures was assessed in WT and Kcnb1 R/+ littermates at P19-83. Individual mice were subjected to 6 Hz of auricular stimulation (0.2 ms pulse width, 3 sec duration) using an electroconvulsive unit (Ugo Basile, Gemonio (VA) Italy). Mice that did not exhibit a seizure on the first stimulation were subjected to a second stimulation (≥ 2 mA higher) separated by a delay of ≥15 minutes. Mice were scored for presence or absence of psychomotor seizure activity, defined as forelimb clonus, rearing, paddling or loss of posture. CC50 curves are represented with n= 2-10 subjects per current stimulus. Stimulus response curves, CC50, and respective confidence intervals (CI) were determined for each sex and genotype using log-probit analysis.
Video-EEG monitoring. Between P23-25, male and female WT, Kcnb1 R/+ and Kcnb1 R/R mice were implanted with prefabricated 3-channel EEG headmounts (Pinnacle Technology, Lawrence, KS, USA). Briefly, mice were anesthetized with isoflurane or ketamine/xylazine and placed in a stereotaxic frame. Headmounts with four stainless steel screws that served as cortical surface electrodes were affixed to the skull with glass ionomer cement. Anterior screw electrodes were 0.5-1 mm anterior to bregma and 1 mm lateral from the midline.
Posterior screws were 4.5-5 mm posterior to bregma and 1 mm lateral from the midline. EEG1 represents recordings from right posterior to left posterior (interelectrode distance ≈2 mm). EEG2 represents recordings from right anterior to left posterior (interelectrode distance ≈5 mm). The left anterior screw served as the ground connection. Following at least 48 hours of recovery, tethered EEG and video data were continuously collected from freely moving mice Sirenia acquisition software (Pinnacle Technology) as previously described (Hawkins et al., 2016) . At least two weeks of EEG was acquired from each subject. Raw data was notch filtered with a 1 Hz window around 60 and 120 Hz prior to analysis. Video-EEG records were analyzed with Persyst13 software (Persyst, Solana Beach, CA, USA), MATLAB (MathWorks, Massachusetts) and EEGLAB (Swartz Center for Computational Neuroscience, California) by a reviewer blinded to genotype. Epileptiform discharges were defined as isolated events with a spike and slow wave morphology, an amplitude of ≥3 times baseline, duration of 150-500 ms, and with increased power in frequencies >20 Hz compared to baseline. Samples with high baseline artifact were excluded from analysis. Neurological Exam. Neurological assessment was based on a modified Irwin screen to evaluate baseline behavior of WT and Kcnb1 G379R mice (Irwin, 1968) . Individual mice were placed in a small static cage for 3 minutes and observed for transfer behavior, body position, spontaneous activity, tremor, gait, pelvic elevation, tail elevation, palpebral closure, piloerection, air puff startle response, trunk curl, limb grasping, Preyer reflex, provoked salivation, and provoked biting. Each parameter was scored as shown in Table S1 and then summed for a total exam for each mouse. Total exam scores are shown with 19-32 mice per genotype. Zero Maze. WT and Kcnb1 G379R mice were evaluated for anxiety-related behavior in an elevated zero maze, a variant on the elevated plus maze that eliminates the ambiguous center region (Shepherd et al., 1994) . Individual mice were placed near the closed arm of the maze and allowed to freely explore for 5 minutes. Limelight software was used to video record each trial, track the position of the mouse, and calculate time spent in closed or open arms and total distance traveled (n= 17-28 mice per genotype). Trials where mice jumped off the maze were excluded from the analysis.
Cliff Avoidance. WT and Kcnb1 G379R mice were evaluated for impulsive behavior using a cliff avoidance test. Individual mice were placed on an elevated platform (16 cm diameter, 25 cm height) for 7 minutes. Number of peering events (defined as the entire head extending over the edge of the platform) and fall/jumping events (defined as the entire body leaving the platform) were recorded. Jumping events were compared using time-to-event analysis. P-values were determined by LogRank Mantel-Cox tests (n=19-29 per genotype).
Marble Burying. Marble movement and burying assay evaluated WT and Kcnb1 G379R mice for phenotypes related to anxiety-and obsessive-compulsive behavior. Individual mice were placed into a static rat cage with 5 cm of corncob bedding and acclimated for 15 minutes. Mice were then briefly removed from the cage while bedding was flattened and 20 marbles were evenly placed across the cage in 5 rows with 4 marbles each, with a small open space at the front of the cage. A baseline image of the cage was taken prior to reintroduction of the mouse and reimaged after the 30-minute trial. The two images were compared for the number of marbles buried, defined by at least ½ of the marble being submerged under the bedding. Total number of marbles moved or buried were compared between groups by two-way repeated measures ANOVA with Sidak's multiple comparisons test (n= 9-25 mice per genotype).
Electrocardiography (ECG).
At 8-10 weeks of age, WT, Kcnb1 R/+ and Kcnb R/R mice were anesthetized with isoflurane and surface ECGs were recorded using a digital Dual Bio Amplifier acquisition system and Powerlab software (ADInstruments, Colorado Springs, CO). Baseline ECG was recorded for at least 4 minutes followed by intraperitoneal administration of isoproterenol (1.5 mg/kg) and an additional 10 minutes of recording. Records were analyzed offline using the ECG Module for LabChart software (ADInstruments). Measurement of QT interval was performed on three sequential 10 second intervals at baseline and 6 minutes after the administration of isoproterenol. QT intervals were corrected for heart rate (QTC) using Bazett's formula. Groups were compared using a two-way repeated measures ANOVA test (GraphPad Prism). Values for post-hoc comparions are reported in the results text and figure legends, and group n's are reported in figure legends. There were no significant differences between sexes on any measurements except 6 Hz seizure threshold. Thus, groups were collapsed across sex for all variables except the 6 Hz seizure threshold.
Statistical Analysis.
Results
KCNB1-G379R affects subcellular localization of K V 2.1 in HEK293T cells
Previous reports demonstrated that KCNB1 variants can alter expression and localization of KV2.1 in CHO-K1 and COS-1 cell lines (Thiffault et al., 2015; Torkamani et al., 2014) .
Additionally, it was shown that exogenously expressed rat KV2.1 (rKV2.1) in HEK293T cells is specifically localized in large PM clusters similar to those seen in neurons (Bishop et al., 2015; Fox et al., 2015; Johnson et al., 2018; Kirmiz et al., 2018a; Kirmiz et al., 2018b; Mohapatra and Trimmer, 2006; Scannevin et al., 1996; Trimmer, 1991) . These clusters are located at ER-PM junctions and result from the interaction of KV2.1 with ER proteins VAPA and VAPB (Fox et al., 2015; Johnson et al., 2018; Kirmiz et al., 2018a; Kirmiz et al., 2018b) .The clustering of KV2.1 and recruitment of VAP proteins at ER-PM junctions is a non-conducting function of KV2.1, which instead is dependent upon serine phosphorylation within the PRC domain, a small motif in the KV2.1 C-terminus (Johnson et al., 2018; Kirmiz et al., 2018a; Kirmiz et al., 2018b) .
To determine whether the KCNB1-G379R variant affected this non-conducting function of KV2.1, we investigated human KV2.1 (hKV2.1) and hKV2.1-G379R expression in HEK293T cells, which lack endogenous KV2 channel expression and are of a neuronal lineage (Shaw et al., 2002; Yu and Kerchner, 1998) .
We first determined whether hKV2.1 formed PM clusters and recruited VAPA proteins to the ER-PM junctions in HEK293T cells. We used two imaging modalities to assess subcellular localization: conventional epifluorescence microscopy to evaluate overall expression pattern, and The rKV2.1-S586A mutation was previously shown to not recruit VAPA to ER-PM junctions (Kirmiz et al., 2018b) . As a control, we compared co-localization and VAPA cluster size of rKV2.1-S586A with WT hKV2.1 or hKV2.1-G379R. Consistent with our previous report, expression of rKV2.1-S586A resulted in a lower PCC value of 0.28 (p<0.0001) and smaller average VAPA cluster size of 0.18±0.02 μm 2 compared to WT hKV2.1 cluster size of 0.63±0.13 μm 2 ( Figure 2B ,E,G). Co-localization PCC values and VAPA cluster sizes were not different between hKV2.1 and rKV2.1, or hKV2.1-G379R and rKV2.1-S586A mutants (Figure 2E,G) . As an additional control, rKV2.1 and hKV2.1-G379R were co-expressed and found to have similar localization and size properties of the hKV2.1-G379R mutation alone, suggesting G379R may exert a dominant negative effect on co-expressed KV2.1 (Figure 2E -G).
Generation and initial characterization of Kcnb1 G379R mice
To model the DEE-associated KCNB1-G379R pathogenic variant in vivo, we used CRISPR/Cas9 genome editing to introduce the G379R missense variant in the mouse Kcnb1 gene. Kcnb1 G379R/+ heterozygous and Kcnb1 G379R/G379R homozygous mutants (abbreviated as Figure 1D ). We initially observed during the course of routine husbandry that Kcnb1 G379R mice exhibited seizures following handling, overt home cage hyperactivity, repetitive jumping, and occasional unexpected deaths in otherwise healthy appearing animals (median age at death P27, range P21-172).
Lower K V 2.1 channel expression in Kcnb1 G379R mice
To evaluate the effect of the Kcnb1 G379R variant on KV2.1 protein expression, we first performed immunoblotting using whole brain membrane preparations. These analyses revealed that whole brain expression of KV2.1 was ≈15% lower in Kcnb1 R/+ heterozygotes and 67% lower in Kcnb1 R/R homozygous mice compared to WT littermates ( Figure 1E ,F). There was also an evident shift in the relative electrophoretic mobility (Mr) from the fully post-translationally modified form (≈125 kDa) toward an Mr of ≈96 kDa, suggesting a deficit in the processing of the Kcnb1 G379R variant into the the mature, fully post-translationally modified species (Figure 1E ,G) (Misonou et al., 2004; Murakoshi et al., 1997) .
To assess the impact of the Kcnb1 G379R variant on neuroanatomy and KV2.1 expression, we performed immunolabeling of brain sections from WT, Kcnb1 R/+ and Kcnb1 R/R mice, as well as Kcnb1 +/and Kcnb1 -/mice for comparison (Speca et al., 2014) . Based on labeling with the DNA-specific dye Hoechst 33258 (data not shown) and consistent with previous observations in Kcnb1 -/mice ( Figure 3A) , the Kcnb1 G379R variant had no overt effect on gross hippocampal neuroanatomy (Speca et al., 2014) . Densitometry of fluorescent signal intensity revealed lower KV2.1 immunolabeling (green) in hippocampal, subicular and neocortical neurons from Kcnb1 G379R mice compared to WT ( Figure 3B,C) , with ≈55% less KV2.1 labeling in Kcnb1 R/+ and ≈80% less in Kcnb1 R/R relative to WT (p=0.0009 and p<0.0001, respectively). However, the lower KV2.1 immunolabeling in Kcnb1 R/R mice was not as dramatic as the complete lack of detectable KV2.1 observed in Kcnb1 -/mice ( Figure 3B,C) .
Additional validation of lower KV2.1 expression due to the Kcnb1 G379R variant was performed by immunolabeling with three additional KV2.1 antibodies, D3/71R, L105/31 and L80/21, each of which detected a similar reduction in KV2.1 ( Figure 4A ). Both D3/71 and L105/31 have binding sites on the KV2.1 protein distinct from one another and from the other anti-KV2.1 antibodies used (Table 2) . Immunolabeling with antibodies against three different regions of KV2.1 supports that the Kcnb1 G379R variant yields lower KV2.1 expression relative to WT. Importantly, to control for possible technical artifacts as the basis of the differing degrees of immunolabeling, parvalbumin and calretinin immunolabeling was performed and found to not differ between the brain sections from Kcnb1 R/+ , Kcnb1 R/R , and WT mice ( Figure 4B ). Kcnb1 G379R also affects expression of KV2.2 and the KV2 channel auxiliary subunit AMIGO-1. Immunolabeling experiments performed on WT, Kcnb1 R/+ and Kcnb1 R/R brain sections revealed lower KV2.2 expression in Kcnb1 R/R versus WT mice ( Figure 3B ,C) (p<0.036).
To further evaluate the effect of the Kcnb1 G379R variant on KV2.2 and AMIGO-1 protein expression, immunoblotting was performed on whole brain membrane preparations ( Figure   3D ,E). Immunoblotting showed that whole brain expression of KV2.2 was ≈30% lower in Kcnb1 R/+ and ≈50% lower in Kcnb1 R/R mice compared to WT littermates. Immunoblotting for AMIGO-1 whole brain expression revealed ≈25% lower expression in Kcnb1 R/+ and ≈50% lower expression in Kcnb1 R/R mice compared to WT littermates ( Figure 3F,G) . The observed reduction of AMIGO-1 in Kcnb1 G379R mice is in contrast to our previous studies of brain sections from Kcnb1 +/and Kcnb1 -/mice (Bishop et al., 2018) , in which AMIGO-1 immunolabeling was only lost in neurons that typically express high levels of KV2.1 relative to KV2.2, but was expressed normally in neurons that express KV2.2, such as CA1 pyramidal neurons ( Figure 3A ).
Kcnb1 G379R affects K V 2.1 subcellular localization
High magnification images of pyramidal neurons in layer 5b of the cortex depict that the Kcnb1 G379R variant affects subcellular localization of KV2.1 channels ( Figure 4C ). Kcnb1 G379R mutant channels have a primarily intracellular distribution with a reduced intensity consistent with immunoblot results (Figure 1E,F, 4C) . Moreover, the intracellular accumulation of residual KV2.1 identified in Kcnb1 R/R mice is consistent with the shift in Mr to a species of ≈96 kDa ( Figure 1E,G) . This suggests Kcnb1 G379R mutant channels fail to reach the PM, and also do not acquire post-translational modifications, characteristic of the fully mature KV2.1 channel (Misonou et al., 2004; Murakoshi et al., 1997) .
Handling-induced seizures in Kcnb1 G379R mice
Based on initial observations of seizures during the course of routine husbandry, we systematically assessed spontaneous behavioral seizures by individually transferring mice to clean cages and observing for 1 min once per week between 6 and 12 weeks of age. During the course of those observations, 42% (10 of 24) Kcnb1 R/R mice exhibited behavioral seizures with forelimb clonus, rearing and falling, sometimes followed by wild running (Figure 5A , Supplemental Video S1). In contrast, Kcnb1 R/+ heterozygous mice (n= 23) and WT littermates (n= 23) did not exhibit any seizures during these observations (p<0.001). Rarely, similar behavioral seizures were observed in Kcnb1 R/+ heterozygotes, but at older ages (>4 months).
Reduced threshold for induced seizures in Kcnb1 G379R mice
We investigated whether the Kcnb1 G379R mutation influenced latency to seizures induced by the volatile chemoconvulsant flurothyl, a GABAA antagonist (van Vliet, 2017) .
Latency to the first generalized tonic-clonic seizure with loss of posture was lower in Kcnb1 R/R mice compared to WT (p<0.0001) and Kcnb1 R/+ mice (p=0.0002). Kcnb1 R/+ mice also had a lower threshold for flurothyl-induced seizures than WT mice (p=0.0187). Average latency was 111 ± 5 sec for Kcnb1 R/R mice, 150 ± 6 sec for Kcnb1 R/+ mice, and 176 ± 8 sec for WT littermates. (Figure 5B ).
We next investigated whether the Kcnb1 mutation influenced latency to psychomotor seizures induced by long duration, low frequency stimulation (6 Hz, 3 sec), a model of pharmacoresistant focal seizures (van Vliet, 2017) . Kcnb1 R/+ heterozygotes and WT littermates were subjected to 6 Hz stimulation and scored for the presence or absence of seizure activity (forelimb clonus, rearing, paddling or loss of posture). Convulsive current (CC) curves were generated as previously described (Finney, 1971) , and population CC50 values (CC at which 50% of mice seized) were determined for each genotype and sex. Both male and female Kcnb1 R/+ mice had lower CC50 values compared to sex-matched WT controls (p<0.0001) ( Figure 5C ). The CC50 values (95% confidence interval) for WT and Kcnb1 R/+ male mice were 19.2 mA (17.2 to 21.2) and 11.3 mA (9.8 to 12.8), respectively. The CC50 values for WT and Kcnb1 R/+ female mice were 15.8 mA (14.2 to 17.5) and 11.3 mA (10.1 to 12.4), respectively. The relative genotype-dependent shift was similar for males and females.
EEG abnormalities in Kcnb1 G379R mice
The handling-induced behavioral seizure events described above corresponded with electrographic generalized tonic-clonic seizures detected during video-EEG monitoring of Kcnb1 R/+ , Kcnb1 R/R and WT mice at 3 to 6 weeks of age ( Figure 6 ). In addition, several types of interictal EEG abnormalities were observed. Both Kcnb1 R/+ and Kcnb1 R/R mice exhibited isolated spike and slow wave complexes ( Figure 6B -E) that have an increase in power across low and high frequencies up to 170 Hz ( Figure 6E ). The occurrence of the isolated spike and slow wave complexes was elevated relative to WT littermates ( Figure 6F ) when quantified over a 24-hour period. In addition, homozygous Kcnb1 R/R mice displayed recurrent, brief runs of rhythmic slow spike and wave complexes (1-2 Hz).
Neurological abnormalities in Kcnb1 G379R mice
A neurological exam was used to evaluate baseline neurological behavior in 3 week old WT, Kcnb1 R/+ and Kcnb1 R/R mice, including analysis of muscle, spinocerebellar, sensory, neuropsychiatric and autonomic functions (Irwin, 1968) . Neurological exam scores were affected by Kcnb1 genotype, with higher scores indicating deficits. Kcnb1 R/+ had an average overall exam score of 17.2 ± 0.4, that was elevated (p=0.0005) compared to the WT control score of 15.1 ± 0.4 ( Figure 7A ). Kcnb1 R/R mice were found to have the highest score, with an average of 19.8 ± 0.5 ( Figure 7A ) (p<0.0001 vs WT and Kcnb1 R/+ , respectively). Differences in the overall exam score were driven largely by differences in activity levels, escape behavior, and trunk curl ( Supplemental Table S1 ). Furthermore, it was noted that upon transfer into the observation cage, 2 of 23 Kcnb1 R/R mice exhibited a tonic-clonic seizure characterized by forelimb clonus with rearing and falling.
Kcnb1 G379R mice exhibit profound hyperactivity
Kcnb1 G379R mice were easily distinguishable from WT littermates in home cages based on their elevated activity level. Baseline activity measured in an open field assay showed that Kcnb1 R/+ mice traveled farther than WT controls, with average distances of 59.3 ± 2.2 m and 45.6 ± 2.0 m, respectively (p=0.0002) ( Figure 7B ). Kcnb1 R/R mice spent the majority of the session moving around the perimeter of the arena, traveling an average distance of 75.8 ± 3.1 m, more than both WT controls and Kcnb1 R/+ mice (p<0.0001 and p<0.0001, respectively) ( Figure   7B ,C,J). Kcnb1 R/R mice spent <5% of their time in the center of the arena compared to WT and Kcnb1 R/+ mice that spent ~10% of the time in the center ( Figure 7C , H, I).
Impulsivity and diminished anxiety-related behaviors in Kcnb1 G379R mice
Along with their noticeably elevated activity, Kcnb1 mutants appeared to have altered impulsivity/anxiety-like behavior. To further assess these behavioral abnormalities, we used the zero-maze, cliff avoidance and marble burying assays. The zero-maze assay evaluated anxiety-related behavior of WT and Kcnb1 mutants by comparing time spent in open versus closed arms. Kcnb1 R/+ mice spent an average of 38.6 ± 1.3% of the test time in open arms compared to WT controls that averaged 31.4 ± 1.9% of time (p=0.0122) ( Figure 7D ). Kcnb1 R/R mice spent more than half their time (55.7 ± 2.3%) in the open arms of the maze, more than both WT and Kcnb1 R/+ littermate mice (p< 0.0001, respectively) ( Figure 7D ). Distance traveled in the zero-maze differed between genotypes and mirrored the effects seen in open field distance traveled ( Figure 7E ).
The cliff avoidance assay takes advantage of the natural tendency of mice to avoid a potential fall from a height and is used to assess inattentive and impulsive behavior (Matsuoka et al., 2005; Yamashita et al., 2013) . WT and Kcnb1 G379R mice were individually placed on an elevated platform and monitored for jumping or stepping off the platform. WT mice rarely (4 of 26) left the platform ( Figure 7F ). Kcnb1 R/+ (≈52%; 15 of 29) and Kcnb1 R/R (≈78%; 18 of 23) mice left the platform more frequently than WT controls (p=0.0088 and p<0.0001, respectively) ( Figure 7F ). In addition, there was an allele dosage effect with homozygous Kcnb1 R/R mice leaving the platform more often than heterozygous Kcnb1 R/+ mice (p=0.0052).
The marble burying assay assessed attention, anxiety, and obsessive-compulsive related behaviors of WT and Kcnb1 mutants. Relative to WT controls, Kcnb1 R/R mice showed little interaction with the marbles, moving few and failing to bury any (p=0.0336) ( Figure 7G ).
Kcnb1 G379R mice exhibit prolonged QT interval
To evaluate cardiac function in Kcnb1 G379R mice, we performed electrocardiography (ECG) and echocardiography (ECHO) studies in Kcnb1 G379R and WT mice (Figure 8 ). Heart ratecorrected QT interval (QTC) was prolonged in Kcnb1 R/R relative to WT littermates, both at baseline (p=0.0292) (Figure 8B ,C) and 6 minutes after isoproterenol administration (p=0.0002) ( Figure 8B,D) . Furthermore, Kcnb1 R/R QTC interval following isoproterenol injection was prolonged relative Kcnb1 R/+ (p=0.0202) ( Figure 8B,D) . There were no genotype-dependent differences detected in ejection fraction or fractional shortening determined by echocardiography (Supplemental Figure S1 , Table S2 ), indicating the absence of contractile dysfunction at 10-14 weeks of age.
Discussion
KCNB1-G379R was identified as a pathogenic de novo variant in a child with DEE.
Electrophysiological studies of KV2.1 channels with the G379R variant in a heterologous expression system demonstrated lower potassium conductance relative to WT, loss of ion selectivity, and gain of a depolarizing inward cation conductance (Torkamani et al., 2014) . In addition, mutant subunits exerted a dominant negative effect on potassium conductance when coexpressed with WT subunits (Torkamani et al., 2014) . We extended in vitro characterization of the KCNB1-G379R variant by demonstrating failure of KV2.1-G379R to induce ER-PM junctions, as well as dominant negative effects on co-expressed WT KV2.1 subunits. This The proband with the KCNB1-G379R de novo variant initially presented with infantile spasms at 8 months of age and later developed multiple seizure types including focal dyscognitive, atonic, and generalized tonic-clonic seizures (Torkamani et al., 2014) . Seizures were difficult to treat and adequate control was not achieved with ACTH, topiramate, valproic acid, pyridoxine, or the ketogenic diet. EEG findings at different time points included hypsarrhythmia, diffuse polyspikes, diffuse polyspike and slow-waves, right temporal spike and waves, and left occipital spikes. Beyond seizures, there was also developmental delay and an autism spectrum disorder diagnosis consistent with atypical Rett syndrome, as well as borderline long QT syndrome (Srivastava et al., 2018; Torkamani et al., 2014) . The Kcnb1 G379R mouse model shares a number of these key phenotypes and will be a useful platform for evaluation of potential therapies for KCNB1 associated DEE.
Electrographic and behavioral seizures in the mice shared features of seizures seen in the proband (Torkamani et al., 2014) . The Kcnb1 G379R mice exhibited multiple seizure types, including epileptiform events coinciding with behavioral arrest reminiscent of focal dyscognitive seizures, as well as generalized tonic-clonic seizures. Numerous EEG abnormalities were noted in Kcnb1 G379R mice, including isolated spike and slow waves and recurrent runs of rhythmic slow spike and wave complexes. These events and features will be useful biomarkers to evaluate potential therapeutic strategies that can normalize the EEG.
Neurobehavioral abnormalities were prominent in the Kcnb1 G379R mice and overlap with features reported in children with KCNB1 encephalopathy (Bar et al., 2019; Calhoun et al., 2017; de Kovel et al., 2017; Marini et al., 2017; Srivastava et al., 2018; Thiffault et al., 2015; Torkamani et al., 2014) . Attention-deficit/hyperactivity disorder or hyperactivity with inattention has been reported in numerous cases of KCNB1 encephalopathy. Kcnb1 G379R mice exhibit profound hyperactivity both in their home and novel environments, and inattention was suggested by failure to interact with marbles in the marble burying assay. In addition, lack of preference for the closed arms in the zero maze could be due to inattention to surroundings and/or reduced anxiety-like behavior. Failure of the cliff avoidance response in Kcnb1 G379R mice may reflect inattention and/or elevated impulsivity, another behavioral problem reported for individuals with KCNB1 encephalopathy. Although visual deficits could explain the observed inattention, there was no deficit in visual placing in Kcnb1 G379R mice and prior characterization of Kcnb1 -/mice included assessment of vision, which detected no impairment (Speca et al., 2014) . Autism spectrum disorder has been reported in more than half of KCNB1 encephalopathy cases, including KCNB1-G379R. Repetitive jumping was another prominent behavior observed in the Kcnb1 G379R mice in their home cages and upon transfer to a novel environment. This perseverative behavior was also previously reported in the Kcnb1 -/mice and may reflect repetitive movements seen in KCNB1 DEE patients with autism spectrum disorder (Speca et al., 2014) .
Previous work demonstrated that global deletion of Kcnb1 in mice resulted in pronounced hyperactivity, reduced anxiety-like behavior, and increased susceptibility to flurothyl and pilocarpine-induced seizures (Speca et al., 2014) . The neurobehavioral phenotypes of Kcnb1 R/R mice and Kcnb1 -/mice were largely similar on the same C57BL/6J background strain. However, the more prominent seizure phenotypes in Kcnb1 G379R mice suggest the mutation is not simply a loss-of-function allele. Spontaneous seizure activity was reported in ≈10% of homozygous Kcnb1 -/mice during the course of routine handling (Speca et al., 2014) . This is similar to the frequency of spontaneous seizure activity observed in heterozygous Kcnb1 R/+ mice, while seizures were observed in almost half of homozygous Kcnb1 R/R mice between 6 and 12 weeks of age. In vitro functional studies of KCNB1-G379R showed change of function effects including loss of voltage-sensitivity and altered ion-selectivity, as well as dominant negative effects when co-expressed with WT subunits (Torkamani et al., 2014) . In addition to alterations in the biophysical properties of KV2.1 channels, the G379R mutation also appeared to exert a dominant negative influence on the expression and subcellular localization of WT KV2.1, KV2.2 and AMIGO-1 subunits. Immunohistochemistry and immunoblotting experiments revealed that both KV2.2 and AMIGO-1 immunoreactivity was substantially lower in sections and whole brain membrane preparations from Kcnb1 R/R mice. KV2.1 and KV2.2 form heteromeric channels, with most complexes containing AMIGO-1 auxiliary subunits (Bishop et al., 2018; Kihira et al., 2010; Peltola et al., 2011a) . We hypothesize that the lower KV2.2 and AMIGO-1 immunoreactivity is due to their altered subcellular localization, as both proteins were diffusely distributed throughout the ER rather than clustered at the PM (for a full discussion see (Bishop et al., 2018) ).
The expression and localization alterations resulting from the Kcnb1 G379R mutant may contribute to the more severe seizure phenotypes observed in Kcnb1 G379R mice as compared to Kcnb1 -/null mice. Future studies will investigate the neurophysiological basis of seizure phenotypes in Kcnb1 G379R mice.
Beyond neurological phenotypes, there have been anecdotal reports of borderline long QT syndrome in patients with KCNB1 associated encephalopathy (kcnb1.org). Additionally, KCNB1 is highly expressed in mouse cardiac tissue and synonymous SNPs in KCNB1 have been associated with long QT syndrome in humans (Iwasa et al., 2001) . Therefore, we performed preliminary evaluation of cardiac phenotypes using ECG and ECHO. Homozygous Kcnb1 R/R mice had prolonged QTC interval relative to WT at baseline and following an isoproterenol challenge. KV2.1 has been shown to contribute to the IKslow component of the mouse cardiac action potential, and a transgenic KV2.1 dominant-negative mutation (N216) was shown to attenuate IKslow resulting in action potential and QT prolongation (Xu et al., 1999) . There was no evidence of structural abnormalities or contractile dysfunction by ECHO ( Supplemental Table   S2 ). Our results suggest that KCNB1 variants could conceivably contribute to spontaneous or induced cardiac arrhythmia (e.g., exposure to proarrythmic drugs), although future studies will be required to further characterize the arrhythmogenic potential of Kcnb1 G379R . Interestingly, mice with homozygous deletion of AMIGO-1, an auxiliary subunit of the KV2.1 channel complex (Peltola et al., 2011b) , also have a prolonged QTC interval (Dickinson et al., 2016) . This provides additional evidence associating the KV2.1 channel complex with QTC prolongation.
In summary, we developed a novel knock-in mouse model of human DEE caused by a missense mutation in Kcnb1 that disrupts both conducting and non-conducting functions of KV2.1 channels. The Kcnb1 G379R mouse model will be valuable for defining the molecular and neurophysiological consequences of Kcnb1 mutation, understanding disease pathophysiology, and evaluating response to therapeutic interventions.
Table 1. List of Primers and Probes Assay
Description Sequence Founder Screening PCR Primer 1 5'-TGGGCTTGCTCATCCTCTTC Primer 2 5'-CTCCGCTTGATGGCTTTCTC Genotyping Kcnb1 G379R Primer 1 5'-GCATCCCCGCCTCTTTCT Primer 2 5'-CAGGAGAGTCTTAGGGTAGATGTCT Probe 1 (WT allele) 5'-VIC-CACCATGACGACCGTT-NFQ Probe 2 (mutant allele) 5'-FAM-CACCATGACGACAGTT-NFQ Genotyping Kcnb1 fs Primer 1 5'-TCTTTGCCGAGAAGGATGAG Primer 2 5'-CCAGGAGAGTCTTAGGGTAGAT Probe 1 (common allele) 5'-VIC-TAGCCCACCAGAAAGAGGC-NFQ Probe 2 (WT allele) 5'-FAM-ATGACGACCGTTGGTTACGG-NFQ Abbreviations: FAM, FAM reporter dye; VIC, VIC reporter dye; NFQ, non-fluorescent quencher one-way ANOVA). Kcnb1 R/+ mice (n=31) had an average score of 17.2 ± 0.4; higher compared to the WT (n=32) score of 15.1 ± 0.4 (***p = 0.0005, Tukey's post-hoc comparisons). Kcnb1 R/R mice (n=23) had the highest score, with an average of 19.8 ± 0.5, compared to WT and Kcnb1 R/+ mice (****, † p<0.0001, respectively; Tukey's). B & C) Baseline activity was assessed using an open-field assay. B) There was a significant effect of genotype on total distance traveled (F(2,72) = 39.11, p<0.0001; one-way ANOVA). Kcnb1 R/+ mice (n=25) traveled an average distance of 59.3 ± 2.2 m, farther compared to WT (n=29) average distance of 45.6 ± 2.0 m (***p = 0.0002, Tukey's). Kcnb1 R/R mice (n=21) traveled an average distance of 75.8 ± 3.1 m, farther than both WT and Kcnb1 R/+ mice (****, † p<0.0001, respectively, Tukey's). C) There was a significant effect of genotype on percent of time spent in the center of the open field (F(2,73) = 11.56, p<0.0001; one-way ANOVA). Kcnb1 R/R mice spent 4.8 ± 0.8% of time in the center, less than both WT (***p = 0.0006, Tukey's) and Kcnb1 R/+ mice ( †p<0.0001, Tukey's). D & E) Anxietyrelated behavior was assessed using a zero-maze assay. D) Time spent in the open arms of the zero-maze was affected by genotype (F(2,70) = 42.07, p<0.0001; one-way ANOVA). Kcnb1 R/+ mice (n=26) spent an average of 38.6 ± 1.3% of the test time in open arms of the maze compared to WT (n=28), who averaged 31.4 ± 1.9% of time (*p = 0.0122, Tukey's). Kcnb1 R/R mice (n=19) spent 55.7 ± 2.3% of time in the open arms of the maze, more than both WT and Kcnb1 R/+ mice (****, †p< 0.0001, respectively, Tukey's). E) There was a significant effect of genotype on total distance traveled in the zero maze (F(2,69) = 30.64, p<0.0001; one-way ANOVA). Total distance traveled was 34.3 ± 2.1 m for Kcnb1 R/R , 25.2 ± 0.9 m for Kcnb1 R/+ , and 20.4 ± 0.8 m for WT (*p = 0.0125 and ****p<0.0001 vs WT, †p<0.0001 vs Kcnb1 R/+ , Tukey's). F) Time to step or jump off the platform was evaluated in the cliff avoidance assay. Kcnb1 R/+ mice left the platform more frequently (≈52%, 15/29) compared to WT (≈15%, 4/26) (**p=0.0088, LogRank Mantel-Cox). Kcnb1 R/R mice (≈78%, 18/23) left the platform more often than both WT and Kcnb1 R/+ mice (****p<0.0001, **p = 0.0052, respectively, LogRank Mantel-Cox). G) Marble burying was significantly affected by genotype (F(2,41) = 3.518, p = 0.0389; two-way repeated measures ANOVA). Relative to WT (n=25), Kcnb1 R/+ mice (n=9) rarely and Kcnb1 R/R mice (n=10) never buried marbles (R/R vs WT, *p = 0.0336, Sidak's). were recorded in 8-10 week old WT, Kcnb1 R/+ and Kcnb1 R/R mice under anesthesia. Baseline recording was acquired for at least 4 minutes prior to adrenergic challenge with isoproterenol (1.5 mg/kg, IP) A) Representative recording of a single sinus beat at baseline in WT, Kcnb1 R/+ and Kcnb1 R/R mice. B) Representative ECG traces from each genotype at baseline (left) and following isoproterenol administration (right). C-D) Both at baseline (C) and 6 minutes following isoproterenol administration (D), heart-rate corrected QT interval (QTC) was affected by genotype (F(2,21)=7.19; two-way repeated measures ANOVA). C) At baseline, Kcnb1 R/R mice had a QTC interval of 55.7 ± 2.1 msec, which was prolonged relative to the WT QTC interval of 48.8 ± 1.2 msec (*p=0.0292, Sidak's). D) Following isoproterenol (1.5 mg/kg, IP) administration, Kcnb1 R/R mice had a QTC interval of 73.2 ± 2.8 msec, which was prolonged relative to the WT and Kcnb1 R/+ QTC intervals of 62.0 ± 1.2 and 65 ± 1.6 msec, respectively (**p=0.0002 and *p=0.0202, respectively; Sidak's). 
